Bionano Genomics NxClinical Software Version 6.2

Bionano Genomics released version 6.2 of its NxClinical software. The newest version includes an integrated genomic scar analysis for homologous recombination deficiency, the company said. The feature, developed by BioDiscovery, can be used to measure genomic instability in a platform-agnostic way, allowing cancer researchers to gain insights from genetic data from a range of array and sequencing assays, including several from Illumina, Thermo Fisher Scientific, and Agilent, Bionano said.